Irinotecan in Treating Patients With Advanced Cancer of the Stomach

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

irinotecan hydrochloride

Trial Locations (19)

32224

Mayo Clinic Jacksonville, Jacksonville

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003137 - Irinotecan in Treating Patients With Advanced Cancer of the Stomach | Biotech Hunter | Biotech Hunter